Laser Application Patents (Class 607/89)
  • Patent number: 10653328
    Abstract: A biological information detection device includes a light source, an image capturing device, and one or more arithmetic circuits. The light source projects dots formed by light onto a target including a living body. The image capturing device includes photodetector cells and generates an image signal representing an image of the target onto which the dots are projected. The one or more arithmetic circuits detect a portion corresponding to at least a part of the living body in the image by using the image signal and calculate biological information of the living body by using image signal of the portion.
    Type: Grant
    Filed: June 21, 2017
    Date of Patent: May 19, 2020
    Assignee: Panasonic Intellectual Property Management Co., Ltd.
    Inventor: Hisashi Watanabe
  • Patent number: 10588535
    Abstract: A method for determining a sequence of activation of a set of brain networks by an electronic device in the course of a predetermined cognitive task. The method includes: obtaining at least one time series of data on encephalographic activities, according to a predetermined sampling value, the data on activities representing a signal captured on the cranial surface by a capture device, during the execution of the predetermined cognitive task by at least one individual, delivering a set having at least one measurements vector per sample of the time series; for each measurements vector, determining connectivity between cortical sources, the cortical sources being obtained through measurements of a measurements vector, delivering a connectivity network; and grouping connectivity networks according to a resemblance parameter delivering a set of groups of grouped connectivity networks, each representing an activity of a given brain network at a given instant.
    Type: Grant
    Filed: March 31, 2016
    Date of Patent: March 17, 2020
    Assignees: UNIVERSITE DE RENNES 1, INSTITUT NATIONALE DE LA SANTE ET DE LA RECHERCHE MEDICALE
    Inventors: Fabrice Wendling, Mahmoud Hassan
  • Patent number: 10561854
    Abstract: The present invention relates to a photo-activated modulation of smooth muscle (PAMS) technology-based skin adhesive-type low level light irradiator system using a mobile communication device. The present invention can monitor and control the charging state of a battery embedded in a skin adhesive-type low level light irradiator, which is adhered to a specific skin area of a human body using medical double-sided tape and emits and radiates visible light for a given time period, thereby inducing a bioactive substance, such as nitric oxide, to be secreted from an internal organ or tissue of the human body which is connected to the light irradiated skin area by a peripheral nerve, in real time and wirelessly using a mobile communication device.
    Type: Grant
    Filed: October 15, 2014
    Date of Patent: February 18, 2020
    Assignee: COLOR SEVEN CO., LTD.
    Inventors: Nam Gyun Kim, Kyong Jun Park, Hea Ja An
  • Patent number: 10517676
    Abstract: A cosmetic method of treating skin tissue with a laser source includes applying a plurality of short pulses of predetermined parameters to ramp up the temperature of the skin tissue to reach a desired temperature and then applying a plurality of short pulses to maintain a temperature dwell time. The predetermined parameters are selected from one or more of: pulse peak power, pulse duration, pulse repetition rate and laser wavelength.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: December 31, 2019
    Assignee: LUMENIS LTD.
    Inventor: Israel Schuster
  • Patent number: 10500095
    Abstract: Embodiments of the invention provide systems and methods for treating the retina and/or other areas of a patient's eye. The procedures may involve using one or more treatment beams (e.g., lasers) to cause photocoagulation or laser coagulation to finely cauterize ocular blood vessels and/or prevent blood vessel growth to induce one or more therapeutic benefits. In other embodiments, a series of short duration light pulses (e.g., between 5-15 microseconds) may be delivered to the retinal tissue with a thermal relaxation time delay between the pulse to limit the temperature rise of the target retinal tissue and thereby limit a thermal effect to only the retinal pigment epithelial layer. Such procedures may be used to treat diabetic retinopathy, macular edema, and/or other conditions of the eye. The treatment beam may be delivered within a treatment boundary or pattern defined on the retina of the patient's eye.
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: December 10, 2019
    Assignee: IRIDEX Corporation
    Inventor: Kingman Yee
  • Patent number: 10463430
    Abstract: A laser therapy device includes a solid-state laser configured for a CW operation and including a pump source, and a controller configured to generate at least one first pulse of the laser in a first-pulse operation. The controller is configured to switch on the pump source to a pump power level S1 at least once during the first-pulse operation. A rise time E, after which the pump power level S1 of the pump source is attainable and starting from the time the pump source is switched on, is in a range of 50 ns to 350 ns.
    Type: Grant
    Filed: July 26, 2012
    Date of Patent: November 5, 2019
    Assignee: CARL SEISS MEDITEC AG
    Inventors: Manfred Dick, Rene Denner, Gerald Kunath-Fandrei
  • Patent number: 10456298
    Abstract: Systems, methods, and devices used to treat eyelids, meibomian glands, ducts, and surrounding tissue are described herein. In some embodiments, an eye treatment device is disclosed, which includes a scleral shield positionable proximate an inner surface of an eyelid, the scleral shield being made of, or coated with, an energy-absorbing material activated by a light energy, and an energy transducer positionable outside of the eyelid, the energy transducer configured to provide light energy at one or more wavelengths, including a first wavelength selected to heat the energy-absorbing material. Wherein, when the eyelid is positioned between the energy transducer and the scleral shield, the light energy from the energy transducer and the heated energy-absorbing material of the scleral shield conductively heats a target tissue region sufficiently to melt meibum within meibomian glands located within or adjacent to the target tissue region.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: October 29, 2019
    Assignee: Tear Film Innovations, Inc.
    Inventors: Brian S. Kelleher, Kabir Gambhir
  • Patent number: 10441808
    Abstract: Methods and devices are provided for activating brown adipose tissue (BAT) with light. Generally, the methods and devices can activate BAT to increase thermogenesis, e.g., increase heat production in the patient, which over time can lead to weight loss and/or improved metabolic function. In one embodiment, a medical device is provided that activates BAT by using light to stimulate nerves that activate the BAT and/or to stimulate brown adipocytes directly, thereby increasing thermogenesis in the BAT and inducing weight loss and/or improved metabolic function through energy expenditure. The light can be configured to directly or indirectly stimulate the nerves and/or the brown adipocytes. The light can be configured to indirectly stimulate the nerves and/or the brown adipocytes by activating a light activatable medium administered to a patient and configured to respond to the light to cause activation of the brown adipose tissue.
    Type: Grant
    Filed: December 21, 2011
    Date of Patent: October 15, 2019
    Assignees: Ethicon Endo-Surgery, Inc., The General Hospital Corporation
    Inventors: Jason L. Harris, Lee M. Kaplan, David N. Plescia, Taylor W. Aronhalt, James W. Voegele, Nicholas Stylopoulos
  • Patent number: 10426971
    Abstract: A phototherapy device with pain location input phototherapy device for relieving nociceptive pain of a body part of a user by illumination of at least a part of the body part. A controllable light source system (LS1, LS2, LS3) comprises at least one light source arranged on a patch structure (PS) so as to allow phototherapeutic illumination of a body part. A user interface (U_I), e.g. a touch panel (TP), is arranged to receive an input from the user regarding a spatial position on the body where the user feels pain. A control system (CS) is arranged to control the controllable light source system (LS1, LS2, LS3) in accordance with said input from the user, e.g. to spatially intensify illumination at the position where the user indicates a sensation of pain. E.g. the device may be wirelessly controlled from the a smart phone, where a map of the body can be displayed, and where the user indicates on this map where he/she feels pain.
    Type: Grant
    Filed: May 19, 2015
    Date of Patent: October 1, 2019
    Assignee: KONINKLIJKE PHILIPS N.V.
    Inventors: Lucas Jacobus Franciscus Geurts, Vincentius Paulus Buil, Maria Estrella Mena Benito, Ramon Eugene Franciscus Van De Ven, Peter Bingley, Adam Henriksson
  • Patent number: 10398908
    Abstract: A system and method for using a sonic wave to influence material in a target structure requires using a confined plasma antenna to generate an electromagnetic carrier wave, ?. The confined plasma antenna also pulses the carrier wave at a sonic frequency, f, to create a sonic wave. In detail, pulsing the carrier wave results in a sequential plurality of solitons which are separated from each other by a periodicity ?, wherein ?<<?. For the present invention, f is selected to resonate with a material (e.g. a cellular structure) in a target structure (e.g. a patient).
    Type: Grant
    Filed: September 15, 2015
    Date of Patent: September 3, 2019
    Assignee: Strathspey Crown Holdings, LLC
    Inventors: Robert Edward Grant, Matthew T. Case
  • Patent number: 10363171
    Abstract: A process for performing retinal phototherapy or photostimulation includes generating a laser light that creates a therapeutic effect to retinal and/or foveal tissues exposed to the laser light without destroying or permanently damaging the retinal or foveal tissue. The laser light is applied to a first treatment area of the retina. After a predetermined interval of time, within a single treatment session, the laser light is reapplied to the first treatment area of the retina. During the interval of time between the laser light applications to the first treatment area, the laser light is applied to one or more additional areas of the retina that is spaced apart from the first treatment area and one another. The laser light is repeatedly applied to each of the areas to be treated until a predetermined number of laser light applications to each area to be treated has been achieved.
    Type: Grant
    Filed: May 6, 2016
    Date of Patent: July 30, 2019
    Assignee: Ojai Retinal Technology, LLC
    Inventors: Jeffrey K. Luttrull, Benjamin W. L. Margolis, David B. Chang
  • Patent number: 10315042
    Abstract: Systems and methods that could reduce the potential for side effects while delivering a reduced amount of light energy and non-light energy to a patient while providing a desired therapeutic effect that might otherwise only be achievable with a higher dose of either the light energy or non-light energy administered alone are disclosed. In certain embodiments, disclosed is a system and method for treating a patient, by administering a combination of light therapy from a light energy source in addition to one, two, or more other non-light energy modalities to a target region of a patient for a synergistic therapeutic effect.
    Type: Grant
    Filed: May 19, 2011
    Date of Patent: June 11, 2019
    Assignee: Pthera LLC
    Inventors: Luis De Taboada, Jackson Streeter
  • Patent number: 10310272
    Abstract: A source assembly for providing light. The source assembly comprises a source element array, and a scanning mirror assembly. The source element array includes a super luminous diode (SLED) array of SLEDs that are configured to emit light. The SLED array is on a single chip. Each SLED in the SLED array may emit light in the same color channel (e.g., green). There may be multiple SLED arrays that each are on respective chips and each are associated with a different color channel (e.g., one is red, one is blue, and one is green). The scanning mirror assembly is configured to scan light emitted from the SLED array (and/or multiple SLED arrays) to an entrance location of an output waveguide (e.g., of a waveguide display) as scanned image light.
    Type: Grant
    Filed: November 27, 2018
    Date of Patent: June 4, 2019
    Assignee: Facebook Technologies, LLC
    Inventor: Maxwell Parsons
  • Patent number: 10278865
    Abstract: Providing neuroprotective therapy for glaucoma includes generating a micropulsed laser light beam having parameters and characteristics, including pulse length, power, and duty cycle, selected to create a therapeutic effect with no visible laser lesions or tissue damage to the retina. The laser light beam is applied to retinal and/or foveal tissue of an eye having glaucoma or a risk of glaucoma to create a therapeutic effect to the retinal and/or foveal tissue exposed to the laser light beam without destroying or permanently damaging the retinal and/or foveal tissue and improve function or condition of an optic nerve and/or retinal ganglion cells of the eye.
    Type: Grant
    Filed: May 3, 2018
    Date of Patent: May 7, 2019
    Assignee: Ojai Retinal Technology, LLC
    Inventors: Jeffrey K. Luttrull, Benjamin W. L. Margolis, David B. Chang
  • Patent number: 10265538
    Abstract: The present invention relates to a composite compact-type fat decomposition device, which is characterized in that fat in the epidermis of the skin is decomposed by a beam radiated from LEDs (310), fat in the dermis of the skin is decomposed by a beam radiated from a laser tube (100), and fat in the hypodermis of the skin is decomposed by a high frequency generated by an RF plate.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: April 23, 2019
    Assignee: You In Kim
    Inventor: You In Kim
  • Patent number: 10202598
    Abstract: Harvested stem cells are activated by treating them with an amplitude modulated laser beam having a wavelength lying in the range of 405 to 980 nanometers. The frequency of the laser beam is modulated within a range of 8 to 12 MHz. Using the activated stem cells, tissue can be repaired and regenerated by preparing the unactivated stem cells, treating the unactivated stem cells with an amplitude modulated laser beam having a pre-determined frequency for obtaining activated stem cells, administering the activated stem cells into a body containing the tissue, and using a homing beam to guide the activated stem cells within the body to the location of the tissue.
    Type: Grant
    Filed: November 11, 2016
    Date of Patent: February 12, 2019
    Inventors: Todd Frank Ovokaitys, John Scott Strachan
  • Patent number: 10194985
    Abstract: A skin treatment device (100) comprises: —a housing (101); —a treatment action performer (110) arranged within the housing (101) for performing a treatment action on the user's skin (2); —a speed sensor (120) for sensing a relative speed between the housing and the user's skin; —a speed feedback signalling device (400); —a control device (140) receiving an output signal from the speed sensor. The control device controls the speed feedback signalling device if the output signal received from the speed sensor is outside a tolerated displacement speed range (R). The tolerated displacement speed range is adapted to the skills of the user to move the device over the skin surface with a constant speed. If the user's skills are relatively low, the control device increases the magnitude of the tolerated displacement speed range.
    Type: Grant
    Filed: May 23, 2014
    Date of Patent: February 5, 2019
    Assignee: KONINKLIJKE PHILIPS N.V.
    Inventors: Tess Speelpenning, Henriette Christine Marie Hoonhout, Aleksey Anatolievich Kharin, Mart Kornelis-Jan Te Velde
  • Patent number: 10179247
    Abstract: An interstitial laser therapy control system is disclosed. The control system includes a thermistor controller apparatus, a microprocessor, a storage device, at least one input device, a display, an electro-mechanical shutter switch, an electro-mechanical emergency shutoff switch, and an electro-mechanical master power switch. The microprocessor is configured to monitor temperatures detected by one or more thermistors connected to the thermistor controller. Based on the temperatures, the microprocessor determines when treatment has been successful and when application of laser energy needs to be halted. The control system also enables an operator to pause and resume treatment using the input device. The electro-mechanical shutter switch sends a signal to a laser source to close a shutter on the laser. The electro-mechanical emergency stop button causes power to be cut off to the laser source.
    Type: Grant
    Filed: February 4, 2008
    Date of Patent: January 15, 2019
    Assignee: Novian Health, Inc.
    Inventors: Anthony J. Tomasello, William Graveman, Kambiz Dowlatshahi, Henry R. Appelbaum
  • Patent number: 10117317
    Abstract: A system includes a chamber, a laser beam apparatus configured to generate a laser beam to be introduced into the chamber, a laser controller for the laser beam apparatus to control at least a beam intensity and an output timing of the laser beam, and a target supply unit configured to supply a target material into the chamber, the target material being irradiated with the laser beam for generating extreme ultraviolet light.
    Type: Grant
    Filed: December 5, 2017
    Date of Patent: October 30, 2018
    Assignee: Gigaphoton Inc.
    Inventors: Tsukasa Hori, Kouji Kakizaki, Tatsuya Yanagida, Osamu Wakabayashi, Hakaru Mizoguchi
  • Patent number: 10105263
    Abstract: A visual prosthesis apparatus and a method for limiting power consumption in a visual prosthesis apparatus. The visual prosthesis apparatus comprises a camera for capturing a video image, a video processing unit associated with the camera, the video processing unit configured to convert the video image to stimulation patterns, and a retinal stimulation system configured to stop stimulating neural tissue in a subject's eye based on the stimulation patterns when an error is detected in a forward telemetry received from the video processing unit.
    Type: Grant
    Filed: December 7, 2012
    Date of Patent: October 23, 2018
    Assignee: Second Sight Medical Products, Inc.
    Inventors: Robert Greenberg, Kelly H McClure, Arup Roy
  • Patent number: 10099066
    Abstract: A laser ionization therapy assembly having a reservoir defined by a peripheral wall and a base; a support device having a support coupling member and a support opening; and a laser module accommodating a laser diode, the laser module having an opening and a laser module coupling member, wherein the support device is fixedly attached to the peripheral wall of the reservoir and the laser module is detachably coupled thereto, wherein the laser diode is positioned at an angle relative to the base of the reservoir so that laser light is directed through the openings of the laser module and support device to a predetermined location within the reservoir at a height of between ½ inch to 1 inch above the base, and wherein the laser light has a wavelength of between about 630 and 640 nm and a peak power of about 10 mW.
    Type: Grant
    Filed: October 27, 2015
    Date of Patent: October 16, 2018
    Assignee: IN CYNC SPORTS CLINIC INC.
    Inventors: Scott Hamilton, James Steve Hamilton
  • Patent number: 10052232
    Abstract: A steerable laser probe may include a handle, and inner bore of the handle, an actuation structure of the handle, a housing tube, and an optic fiber disposed within the inner bore of the handle and the housing tube. The housing tube may include a first housing tube portion having a first stiffness and a second housing tube portion having a second stiffness. The second stiffness may be greater than the first stiffness. A surgeon may aim the steerable laser probe by varying a rotational position of the handle and an amount of compression of the actuation structure.
    Type: Grant
    Filed: December 22, 2015
    Date of Patent: August 21, 2018
    Assignee: Katalyst Surgical, LLC
    Inventors: Gregg D Scheller, Matthew N Zeid
  • Patent number: 10052229
    Abstract: A system and method for treating ophthalmic target tissue, including a light source for generating a beam of light, a beam delivery system that includes a scanner for generating patterns, and a controller for controlling the light source and delivery system to create a dosimetry pattern of the light beam on the ophthalmic target tissue. One or more dosage parameters of the light beam vary within the dosimetry pattern, to create varying exposures on the target tissue. A visualization device observes lesions formed on the ophthalmic target tissue by the dosimetry pattern. The controller selects dosage parameters for the treatment beam based upon the lesions resulting from the dosimetry pattern, either automatically or in response to user input, so that a desired clinical effect is achieved by selecting the character of the lesions as determined by the dosimetry pattern lesions.
    Type: Grant
    Filed: November 24, 2015
    Date of Patent: August 21, 2018
    Assignee: Topcon Medical Laser Systems, Inc.
    Inventors: Daniel V. Palanker, Dan E. Andersen
  • Patent number: 10046327
    Abstract: Tweezers, in particular for handling histological preparations, preferably thin tissue specimens, with two limbs connected elastically at one end, and with tips formed at the other, free end of the limbs and together forming an engagement area, wherein a central area serves for holding and actuating the limbs in order to bring the tips into contact with each other, are characterized in that the tips and/or the connection area of the limbs are designed as a housing with a storage medium for storing energy, and in that the storage medium directly or indirectly heats the engagement area or the tips to a predefined temperature.
    Type: Grant
    Filed: May 22, 2015
    Date of Patent: August 14, 2018
    Assignee: pfm medical ag
    Inventors: Erwin Schneider, Steffen Kraus
  • Patent number: 10029024
    Abstract: A system for treating, in particular cleansing, wounds with a fluid jet. The system includes a handpiece with a main body with a front end with an emergence opening for the emergence of the fluid jet. The system furthermore has at least one light-emitting light source, which irradiates aerosols created when cleansing the wound. The system enables wound cleansing with simultaneous decontamination of the aerosols created in the process such that the risk of contamination of the surroundings is reduced and preferably with simultaneously treating the wound with UV light.
    Type: Grant
    Filed: September 4, 2014
    Date of Patent: July 24, 2018
    Assignee: MEDAXIS AG
    Inventors: Jérôme Bernhard, Lukas Christen, Albora De Pablo Peña, Kuno Limacher, Martin Schug, Maryline Simon, Beat Widmer, Roland Wiget
  • Patent number: 10029114
    Abstract: A system and method for recuperating cell metabolism, which comprises an energy wave generator has an energy wave's frequency control mode. The energy wave's frequency control mode includes multiple controls for acting the energy wave generator to generate and emit energy waves each with a corresponding energy density. The energy density is calculated by a corresponding base frequency, a sweep bandwidth of the corresponding base frequency, an emission rate and a total time of emission in a duty cycle, so that the energy waves with the corresponding energy densities effecting on the body of animals or human to improve the function of cell metabolism.
    Type: Grant
    Filed: October 11, 2016
    Date of Patent: July 24, 2018
    Assignee: Taiwan Resonant Waves Research Corp.
    Inventor: Wen-Chieh Chang
  • Patent number: 10016231
    Abstract: A medical apparatus includes a treatment device configured to be capable of treating a subject by applying energy to the subject, an optical fiber including a light emitting face for emitting light into the subject, the optical fiber being connected to the treatment device, and a shield portion that is disposed in front of the light emitting face of the optical fiber, the shield portion being configured to expose the light emitting face when the treatment device does not perform a treatment operation and to shield the light emitting face when the treatment device performs the treatment operation.
    Type: Grant
    Filed: May 3, 2017
    Date of Patent: July 10, 2018
    Assignee: OLYMPUS CORPORATION
    Inventors: Makoto Igarashi, Takeshi Watanabe, Yuji Hirai, Kenichi Kimura, Satoshi Homma, Hiroshi Miyajima, Hiroyoshi Yajima
  • Patent number: 9999785
    Abstract: Unactivated stem cells are activated by treating them with an amplitude modulated laser beam having a wavelength lying in the range of 405 to 980 nanometers. The laser beam is modulated within a range of 8 to 12 MHz. Using the activated stem cells, tissue can be repaired and regenerated by preparing the unactivated stem cells, treating the unactivated stem cells with an amplitude modulated laser beam having a pre-determined frequency for obtaining activated stem cells, administering the activated stem cells into a body containing the tissue, and using a homing beam to guide the activated stem cells within the body to the location of the tissue.
    Type: Grant
    Filed: May 30, 2015
    Date of Patent: June 19, 2018
    Inventors: Todd Frank Ovokaitys, John Scott Strachan
  • Patent number: 9993659
    Abstract: Methods of altering the rate of axonal transport are provided in several embodiments. Some embodiments alter axonal transport in a patient in need of an enhancement of axonal transport to alleviate symptoms of a disease or injury. The methods further include delivering electromagnetic radiation to at least one portion of the brain, spinal cord, or peripheral nervous system of a patient sufficient to effect an alteration in axonal transport in the patient.
    Type: Grant
    Filed: June 16, 2010
    Date of Patent: June 12, 2018
    Assignee: Pthera, LLC
    Inventors: Jackson Streeter, Luis De Taboada
  • Patent number: 9877378
    Abstract: A system includes a chamber, a laser beam apparatus configured to generate a laser beam to be introduced into the chamber, a laser controller for the laser beam apparatus to control at least a beam intensity and an output timing of the laser beam, and a target supply unit configured to supply a target material into the chamber, the target material being irradiated with the laser beam for generating extreme ultraviolet light.
    Type: Grant
    Filed: September 28, 2016
    Date of Patent: January 23, 2018
    Assignee: Gigaphoton Inc.
    Inventors: Tsukasa Hori, Kouji Kakizaki, Tatsuya Yanagida, Osamu Wakabayashi, Hakaru Mizoguchi
  • Patent number: 9782222
    Abstract: This invention is an improved method and device for treating varicose veins 200 or the greater saphenous vein 202. The method comprises the use of infrared laser radiation in the region of 1.2 to 1.8 um in a manner from inside the vessel 200 or 202 such that the endothelial cells of the vessel wall 704 are damaged and collagen fibers in the vessel wall 704 are heated to the point where they permanently contract, the vessel 200 or 202 is occluded and ultimately resorbed. The device includes a laser 102 delivered via a fiber optic catheter 300 that may have frosted or diffusing fiber tips 308. A motorized pull-back device 104 is used, and a thermal sensor 600 may be used to help control the power required to maintain the proper treatment temperature.
    Type: Grant
    Filed: October 23, 2009
    Date of Patent: October 10, 2017
    Assignee: COOL TOUCH INCORPORATED
    Inventors: David R. Hennings, Mitchell P. Goldman, Robert A. Weiss, Eric B. Taylor, Don Johnson
  • Patent number: 9752138
    Abstract: The present invention relates to a method of preparing a population of stem cells for autologous implantation to a subject. The cells are activated by irradiating the cells with one or more wavelengths of yellow and red and/or green light. In particular, the cells are irradiated with 575-595 nm (5-20 mW), and 630-635 nm or 660-670 nm (10-100 mW) and/or 510-540 nm (10-60 mW) of monochromatic light for 30-60 mins. Preferably the stem cells are adipose-derived stem cells. Also the invention relates to therapeutic applications of the activated stem cells.
    Type: Grant
    Filed: October 4, 2013
    Date of Patent: September 5, 2017
    Assignee: ADISTEM LTD.
    Inventors: Bill Paspaliaris, James Andrew Farrant Thornton
  • Patent number: 9737727
    Abstract: Various embodiments are described herein that generally relate to a low-level laser therapy (LLLT) device to aid in at least one of the prevention and treatment of hair loss, rejuvenation of hair, and stimulation of hair regrowth for a certain percentage of users. In at least one embodiment, a plurality of emitters and bristles may be arranged in rows on a concave active surface of a housing for facing a treatment surface of the user. In some embodiments, the device is a laser therapy helmet device, wherein a portion of the device rotates relative to the treatment surface during use. In at least some embodiments, the device may further comprise a plurality of modes of operation for delivering different amounts of energy to the treatment surface.
    Type: Grant
    Filed: October 9, 2014
    Date of Patent: August 22, 2017
    Inventor: Martin G. Unger
  • Patent number: 9707129
    Abstract: Embodiments of the invention provide systems and methods for treating the retina and/or other areas of a patient's eye. The procedures may involve using one or more treatment beams (e.g., lasers) to cause photocoagulation or laser coagulation to finely cauterize ocular blood vessels and/or prevent blood vessel growth to induce one or more therapeutic benefits. In other embodiments, a series of short duration light pulses (e.g., between 5-15 microseconds) may be delivered to the retinal tissue with a thermal relaxation time delay between the pulse to limit the temperature rise of the target retinal tissue and thereby limit a thermal effect to only the retinal pigment epithelial layer. Such procedures may be used to treat diabetic retinopathy, macular edema, and/or other conditions of the eye. The treatment beam may be delivered within a treatment boundary or pattern defined on the retina of the patient's eye.
    Type: Grant
    Filed: January 14, 2016
    Date of Patent: July 18, 2017
    Assignee: IRIDEX Corporation
    Inventor: Kingman Yee
  • Patent number: 9696395
    Abstract: Provided are apparatuses and methods for magnetic resonance imaging (MRI). The magnetic resonance imaging (MRI) method includes applying radio frequency (RF) pulses to an object in a magnetic field, the RF pulses having different frequency bands for each of at least two types of nucleus in the object; applying predetermined pulse sequences for each type of nucleus to the object; receiving magnetic resonance signals emitted by each nucleus in response to the RF pulses and the predetermined pulse sequences; and generating an image of the object based on the received magnetic resonance signals.
    Type: Grant
    Filed: October 28, 2013
    Date of Patent: July 4, 2017
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Young-beom Kim, Yeun-chul Ryu, Jae-mock Yi
  • Patent number: 9643027
    Abstract: A waveguide neural interface device including: a neural device implantable in tissue and including an array of electrode sites that electrically communicate with their surroundings, in which the array of electrode sites includes at least one recording electrode site; and a waveguide, coupled to the neural device, that carries light along a longitudinal axis and includes a light directing element that redirects the carried light from the waveguide to illuminate selectively targeted tissue, in which at least a portion of the redirected light is directed laterally away from the longitudinal axis and the recording electrode site is configured to sample illuminated tissue. A method for assembling a waveguide neural interface device is also described.
    Type: Grant
    Filed: October 23, 2014
    Date of Patent: May 9, 2017
    Assignee: NEURONEXUS TECHNOLOGIES, INC.
    Inventors: John P. Seymour, Mayurachat Ning Gulari, Daryl R. Kipke, Kc Kong
  • Patent number: 9636522
    Abstract: A method of biostimulating phototherapy is provided. The method comprises illuminating a subject's body portion (1) with light having a first wavelength in the range of 600-900 nm (17) and reducing and preventing hyperthermia of the body portion by illuminating the body portion with light having a second wavelength which is at least one of in the range of 400-600 nm and in the range of 900-2500 nm (19). Further, a phototherapy device (21) is provided which comprises a first light source (25) and a second light source (26). The first light source is configured to emit light (17) having a first wavelength which is in the range of 600-900 nm. The second light source is configured to emit light (19) having a second wavelength which is at least one of in the range of 400-600 nm and in the range of 900-2500 nm.
    Type: Grant
    Filed: August 4, 2011
    Date of Patent: May 2, 2017
    Assignee: Koninklijke Philips N.V.
    Inventors: Gerrit Oversluizen, Frank Anton Van Abeelen, Liesbeth Van Pieterson, Guofu Zhou, Tim Dekker
  • Patent number: 9610460
    Abstract: An exemplary method includes selecting at least one light source configured to generate light at a particular wavelength and applying the light to tissue following an ischemic event. Applying the light to the tissue inhibits cytochrome c oxidase activity. Another exemplary method includes selecting at least one light source configured to generate light at a particular wavelength and applying the light to tissue following an ischemic event and prior to either reoxygenation of the tissue or clinical intervention to reduce cell damage. An exemplary light therapy device includes at least one light source configured to generate light having a wavelength of at least one of approximately 730-770 nm, 850-890 nm, 880-920 nm, and 930-970 nm.
    Type: Grant
    Filed: August 29, 2014
    Date of Patent: April 4, 2017
    Assignee: Wayne State University
    Inventors: Maik Huttemann, Icksoo Lee, John Kamholz, Lawrence Grossman, Karin Przyklenk, Thomas Sanderson
  • Patent number: 9579081
    Abstract: A device for a bimodal diagnostic probe with optical and ultrasonic imaging, the probe including a main body supporting an ultrasonic transducer at its front end. The device includes a shell, an illumination mechanism mounted on a front end of the shell to light outside of the shell, and a collection or detection mechanism mounted on the front end of the shell to collect or detect an optical signal produced outside the shell. The shell includes an attachment mechanism to reversibly assemble it around the main body of the probe, with the illumination mechanism and the collection or detection mechanism mounted on the shell.
    Type: Grant
    Filed: June 7, 2012
    Date of Patent: February 28, 2017
    Assignees: Commissariat à l'énergie atomique et aux énergies alternatives, SA VERMON
    Inventors: Jérôme Boutet, An Nguyen-Dinh, Mathieu Debourdeau, Odile Messineo, Christophe Notard
  • Patent number: 9511262
    Abstract: A boxing-based fitness training regimen takes place in a training area suffusing with UV light from one or more UV light sources. Non-UV lighting in the training area is adjusted to a level of semi-darkness, in which non-luminescent objects are visible but luminescent objects clearly stand out. Multiple training regimen stations located in the training area can include heavy bag, speed bag, double-end bag, medicine ball, skip rope, shadow boxing and focus mitt regimens. Within each station, one or more items of training equipment, such as bags, gloves, hand wraps, focus mitts, medicine balls and/or jump ropes, are provided. Some or all of the training equipment at each station is UV luminescent. On some items of training equipment, there are luminescent indicia, which provide as visual cues for sequencing and/or timing of movements. These luminescent indicia can be color-coded to operate in conjunction with correspondingly color-coded visual prompts from a nearby display screen, such as an LED display.
    Type: Grant
    Filed: June 17, 2015
    Date of Patent: December 6, 2016
    Inventor: Scott DePompe
  • Patent number: 9468764
    Abstract: Methods of nerve signal differentiation, methods of delivering therapy using such nerve signal differentiation, and to systems and devices for performing such methods. Nerve signal differentiation may include locating two electrodes proximate nerve tissue and differentiating between efferent and afferent components of nerve signals monitored using the two electrodes.
    Type: Grant
    Filed: January 27, 2014
    Date of Patent: October 18, 2016
    Assignee: Medtronic, Inc.
    Inventors: Xiaochong Zhou, John Edward Burnes, Lilian Kornet, Richard N. M. Cornelussen
  • Patent number: 9449382
    Abstract: A computer-controlled system determines attributes of a frexel, which is an area of human skin, and applies a reflectance modifying agent (RMA) at the pixel level to automatically change the appearance of human features based on one or more digital images. The change may be based on a digital image of the same frexel, for as seen in a prior digital photograph captured previously by the computer-controlled system. The system scans the frexel and uses feature recognition software to compare the person's current features in the frexel with that person's features in the digital image. It then calculates enhancements to the make the current features appear more like the features in the digital image, and it applies the RMA to the frexel to accomplish the enhancements. Or the change may be based on a digital image of another person, through the application of RMAs.
    Type: Grant
    Filed: October 31, 2013
    Date of Patent: September 20, 2016
    Assignee: TCMS Transparent Beauty, LLC
    Inventors: Albert D. Edgar, David C. Iglehart, Rick B. Yeager
  • Patent number: 9427826
    Abstract: A hand-guided marking system (1) is disclosed, which is furnished with a radiation source (2) for applying a marking (100) to a surface (101) of a workpiece (102). A camera (4) and at least one illumination device (6) are used for recording a part of the surface (101) of the workpiece (102). A protective housing (10) is mounted on a carrier frame (12) and has an opening (14) in the protective housing (10) that is located opposite the surface (101) of the workpiece (102). The beam source (2) is positioned in the carrier frame (12) in such manner that an optical axis (16) of the beam source (2) passes through the opening of the protective housing (10).
    Type: Grant
    Filed: June 18, 2012
    Date of Patent: August 30, 2016
    Assignee: Schaeffler Technologies AG & Co. KG
    Inventors: Mario Giese, Stephan Berthold
  • Patent number: 9358068
    Abstract: An apparatus for treating a subcutaneous fat region is provided. The apparatus includes a housing that has a skin contacting portion defining a chamber. The apparatus also includes a first spaced region in the housing through which a coolant passes and a second spaced region in the housing that is at least partially evacuated of air. The apparatus further includes a source of electromagnetic radiation, a source of vacuum in fluid communication with the chamber, and a source for the coolant.
    Type: Grant
    Filed: March 3, 2014
    Date of Patent: June 7, 2016
    Assignee: Candela Corporation
    Inventors: Kevin T. Schomacker, Xiaoming Shang, Hebert R. Otterson, Antonio Paulino
  • Patent number: 9333371
    Abstract: A method for providing localized heating of the dermal layers of skin of a patient, using energy in the form of a group of pulses having defined parameters in a controlled manner. This method preferably uses an optical delivery system to deliver pulsed energy to a specific spot of skin so that targeted layers of the affected skin are heated to a desired temperature range. The temperature range is optimally selected to maximize treatment efficacy while minimizing pain to the patient. Example applications include reducing wrinkles, acne, hair, scar tissue, warts, and promoting wound healing. In this method, the temperature of the selected locus rises quickly to the desired temperature range, then is maintained within a controlled range with a relatively flat temperature profile. The method maintains the temperature by controlling one or more of a pulse energy intensity, pulse width, and pulse frequency or time delay between pulses.
    Type: Grant
    Filed: October 29, 2013
    Date of Patent: May 10, 2016
    Assignee: SemiNex Corporation
    Inventors: David M. Bean, Matthew Hamerstrom, Alyssa Bean
  • Patent number: 9326511
    Abstract: The invention provides the use of a compound of formula (I), or metallated derivative thereof, for killing, inhibiting or preventing the growth of a microbial biofilm: wherein X1, X2, X3, X4, Y1, Y2, Y3, Y4 and Z have meanings given in the description. The biofilm may be on a living or inert support. Preferably, the microorganisms are selected from the group consisting of bacteria and fungi.
    Type: Grant
    Filed: October 23, 2009
    Date of Patent: May 3, 2016
    Assignee: Destiny Pharma Limited
    Inventors: William Guy Love, William Rhys-Williams
  • Patent number: 9314302
    Abstract: A method of cosmetically treating a superficial area of mammalian skin by irradiating the skin with a source of divergent electromagnetic radiation of between 900 nm to 1500 nm, and use of electromagnetic radiation of specified wavelengths. The cosmetic treatment includes reducing or alleviating or removing or diminishing wrinkles or fine lines, rejuvenating skin, retarding or reversing visible signs of aging, improving skin elasticity, tone, texture and appearance and beautifying facial, breast, arm, buttock, thigh, stomach or neck skin.
    Type: Grant
    Filed: June 21, 2005
    Date of Patent: April 19, 2016
    Assignee: Virulite LLC
    Inventor: Gordon Rex Paterson Dougal
  • Patent number: 9242100
    Abstract: Various aspects of the present disclosure are directed toward an implantable electrostimulation device, a plurality of sensing and pacing elements, and a fine wire lead extending in a sealed relationship from the electrostimulation device and to the plurality of sensing and pacing elements. The fine wire lead includes multiple discrete conductors and a drawn silica or glass fiber core, a polymer cladding on the drawn silica or glass fiber core, and a conductive metal cladding over the polymer cladding. Additionally, the fine wire lead simultaneously delivers different electrical signals or optical signals between the sensing and pacing elements and the electrostimulation device.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: January 26, 2016
    Assignee: NuAx, Inc.
    Inventors: Robert Gilmore Walsh, Jin Shimada, Michael E. Grant, James E. Shapland
  • Patent number: 9216300
    Abstract: A phototherapy apparatus with interactive user interface for treating biological tissue of an animal or human target. The user interface comprises intuitive graphic menus which allow the clinicians or practitioners to define the properties of the biological tissue through easily observable physical characteristics such as weight, skin color, and hair color of the patient. The central control unit of the phototherapy apparatus then automatically optimizes the parameters of the light source according to the properties of the biological tissue and generates an appropriate treatment protocol to produce the optimum phototherapy result.
    Type: Grant
    Filed: March 26, 2014
    Date of Patent: December 22, 2015
    Assignee: BWT Property, Inc.
    Inventors: Brian Pryor, Sean Xiaolu Wang
  • Patent number: 9067062
    Abstract: The invention relates to an irradiation-cooling combination for application in photodynamic therapy having an irradiation element (120), a cooling element (130) permeable by the emitted radiation in an irradiation pass-through direction, wherein said cooling element is designed for attachment between the irradiation element (120) and a treatment surface (160) of a patient. The cooling element (130) has an optical pass-through surface that can be cooled as an attachment to the treatment surface (160). Additional components of the invention are a first fastening device (150) for defined positioning of the irradiation-cooling combination opposite the treatment surface (160), a second fastening device (140) for attaching the irradiation element (120) on the cooling element (130), a control unit (110) and a power supply (100). The invention provides effective pain management during photodynamic therapy in connection with a mobile treatment system and larger treatment areas by means of a uniform radiation field.
    Type: Grant
    Filed: March 17, 2010
    Date of Patent: June 30, 2015
    Inventor: Norbert Hilty